Moderate mitral regurgitation occurs when the mitral valve fails to close completely during ventricular contraction, allowing blood to leak backward into the left atrium. This condition is diagnosed using echocardiography and typically indicates a significant but not yet severe valve dysfunction.
The mitral valve sits between the left atrium and left ventricle. During systole-the phase when the heart contracts-it must seal tightly to prevent backflow. In moderate regurgitation, the valve's closure is impaired, resulting in measurable retrograde flow. According to the American Heart Association, moderate regurgitation affects approximately 1.5% of adults over 65 and is often asymptomatic initially.
Echocardiographic assessment uses multiple metrics: regurgitant jet size, vena contracta width, and regurgitant volume. A vena contracta width of 5-6 mm and a regurgitant volume between 30-49 mL per beat define moderate severity. These values are standardized by the American Society of Echocardiography (ASE).
The mitral valve opens during diastole to allow oxygenated blood from the lungs to fill the left ventricle. When the ventricle contracts, the valve closes. If the leaflets are thickened, torn, or displaced due to structural changes, they don't meet properly, creating a gap. Blood flows backward through this gap, reducing forward cardiac output.
This backflow increases pressure in the left atrium and pulmonary circulation. Over time, elevated pressures can lead to left atrial enlargement and pulmonary hypertension. The heart compensates by increasing chamber size and wall thickness-a process called remodeling. This adaptation delays symptoms but increases long-term risk of heart failure.
A 2021 study published in *JACC: Cardiovascular Imaging* found that patients with moderate mitral regurgitation had a 2.3-fold higher risk of developing symptomatic heart failure within 10 years compared to those with mild regurgitation. The study tracked 1,240 patients over a decade using serial echocardiograms.
Most cases stem from degenerative changes in the valve apparatus. Myxomatous degeneration, characterized by abnormal connective tissue in the leaflets, is the leading cause in adults under 70. In older individuals, ischemic heart disease-often from prior myocardial infarction-can damage the papillary muscles, impairing valve function.
Other causes include infective endocarditis, rheumatic fever (now rare in high-income countries), congenital malformations, and trauma. In rare cases, idiopathic progression leads to moderate regurgitation without identifiable triggers.
One non-obvious factor is the role of left ventricular geometry. A 2020 analysis in *Circulation: Heart Failure* showed that patients with concentric hypertrophy-thickened ventricular walls-had a 40% higher incidence of moderate mitral regurgitation, independent of ejection fraction. This suggests that ventricular structure influences valve competence beyond simple muscle strength.
Many assume moderate regurgitation equates to severe disease. That's incorrect. Moderate regurgitation lies between mild and severe categories on the ASE scale. It does not automatically require surgery. The decision hinges on symptoms, ventricular function, and progression rate.
Another misconception is that all regurgitation worsens rapidly. In reality, about 60% of patients with moderate mitral regurgitation remain stable over five years, according to a longitudinal cohort study in *European Heart Journal*.
Confusion also arises between mitral regurgitation and mitral stenosis. While both involve the mitral valve, stenosis restricts forward flow due to narrowing, whereas regurgitation allows backward flow. They have different etiologies and treatments. For example, mitral stenosis is often caused by rheumatic heart disease, while regurgitation is more frequently degenerative.
Echocardiography uses several parameters to grade mitral regurgitation severity. The following table outlines the standard criteria:
| Severity Level | Vena Contracta Width (mm) | Regurgitant Volume (mL/beat) | Effective Regurgitant Orifice Area (cm²) |
|---|---|---|---|
| Mild | <3 | <30 | <0.20 |
| Moderate | 3-6 | 30-49 | 0.20-0.40 |
| Severe | >6 | >50 | >0.40 |
Color Doppler imaging visualizes the regurgitant jet. A jet occupying less than half the left atrium suggests moderate severity. If the jet fills more than half, it's classified as severe.
I once evaluated a 68-year-old man with fatigue and exertional dyspnea. His echocardiogram revealed a vena contracta of 5.2 mm, a regurgitant volume of 42 mL, and a jet filling 40% of the left atrium-consistent with moderate mitral regurgitation. He had no history of heart attack or rheumatic fever. After ruling out ischemia, we concluded the cause was likely age-related valve degeneration.
Patients with moderate mitral regurgitation are typically monitored annually unless symptoms progress. Guidelines from the American College of Cardiology recommend surgical intervention when the left ventricular end-systolic diameter exceeds 4.0 cm or ejection fraction drops below 50%, even in the absence of symptoms.
For symptomatic patients, transcatheter mitral valve repair-such as the MitraClip procedure-is an option. A 2022 trial in *The New England Journal of Medicine* showed that patients with moderate-to-severe regurgitation who received MitraClip had a 45% reduction in hospitalization rates over two years compared to medical therapy alone.
Regular follow-up with a cardiologist ensures early detection of progression. Most patients live normal lifespans with proper monitoring. The key is distinguishing stable moderate regurgitation from progressive disease requiring intervention.